Success Metrics

Active Trials
1(20%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A

Trials by Status

recruiting120%
unknown240%
not_yet_recruiting120%
withdrawn120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

NCT04134169
unknown

Evalution the Safety and Efficacy in Atopic Dermatitis Patients

NCT03962387
not_yet_recruiting

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

NCT04730024
unknown

Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients

NCT04087863
withdrawn

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

NCT02069717

Clinical Trials (5)

Showing 5 of 5 trials
NCT04134169

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

Recruiting
NCT03962387

Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Unknown
NCT04730024

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Not Yet Recruiting
NCT04087863

Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Unknown
NCT02069717

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5